DanCann Pharma Management
Management criteria checks 2/4
DanCann Pharma's CEO is Jeppe Rasmussen, appointed in Jan 2018, has a tenure of 6.83 years. directly owns 0.23% of the company’s shares, worth €2.63K. The average tenure of the management team and the board of directors is 3.7 years and 3.6 years respectively.
Key information
Jeppe Rasmussen
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 6.8yrs |
CEO ownership | 0.2% |
Management average tenure | 3.7yrs |
Board average tenure | 3.6yrs |
Recent management updates
Recent updates
CEO
Jeppe Rasmussen (29 yo)
6.8yrs
Tenure
Mr. Jeppe Krog Rasmussen has been Director of Dancann Pharma A/S since September 20, 2022. He Founded and serves as Chief Executive Officer of Dancann Pharma A/S since 2018 and serves as its Member of Exec...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 6.8yrs | no data | 0.23% € 2.6k | |
Chief Financial Officer | 1.8yrs | no data | no data | |
Head of Production | 3.7yrs | no data | no data | |
Chief Commercial Officer | 4.8yrs | no data | no data | |
Head of Quality Assurance | 2.3yrs | no data | no data |
3.7yrs
Average Tenure
Experienced Management: DAN's management team is considered experienced (3.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 2.2yrs | no data | 0.23% € 2.6k | |
Chairman of the Board | 4.8yrs | no data | 0.027% € 307.2 | |
Vice-Chairman | 3.6yrs | no data | 0.016% € 181.6 |
3.6yrs
Average Tenure
40yo
Average Age
Experienced Board: DAN's board of directors are considered experienced (3.6 years average tenure).